{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antiviral", "Cananga odorata", "Hep38.7-Tet cells", "HepG2-NTCP cells", "hepatitis B virus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "31956259", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "15"}, "DateRevised": {"Year": "2020", "Month": "06", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "12"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1883-0498", "JournalIssue": {"Volume": "65", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "12"}}, "Title": "The Kobe journal of medical sciences", "ISOAbbreviation": "Kobe J Med Sci"}, "ArticleTitle": "Antiviral Activity of Cananga odorata Against Hepatitis B Virus.", "Pagination": {"StartPage": "E71", "EndPage": "E79", "MedlinePgn": "E71-E79"}, "Abstract": {"AbstractText": ["Chronic hepatitis B virus (HBV) infection can lead to liver cirrhosis and hepatocellular carcinoma. Current therapeutic drugs for chronic hepatitis B using pegylated interferons and nucleos(t)ide analogs have limited efficacy. Therefore, the development of novel and safe antivirals is required. Natural products including medicinal plants produce complex and structurally diverse compounds, some of which offer suitable targets for antiviral screening studies. In the present study, we screened various crude extracts from Indonesian plants for anti-HBV activity by determining their effects on the production of extracellular HBV DNA in Hep38.7-Tet cells and HBV entry onto a HBV-susceptible cell line, HepG2-NTCP, with the following results: (1) In Hep38.7-Tet cells, Cananga odorata exhibited the highest anti-HBV activity with a 50% inhibitory concentration (IC50) of 56.5 \u00b5g/ml and 50% cytotoxic concentration (CC50) of 540.2 \u00b5g/ml (Selectivity Index: 9.6). (2) The treatment of HepG2-NTCP cells with Cassia fistula, C. odorata, and Melastoma malabathricum at concentrations of 100 \u00b5g/ml lowered the levels of HBsAg production to 51.2%, 58.0%, and 40.1%, respectively, compared to untreated controls, and IC50 and CC50 values of C. odorata were 142.9 \u00b5g/ml and >400 \u00b5g/ml. In conclusion, the C. odorata extract could be a good candidate for the development of anti-HBV drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan."}, {"Identifier": [], "Affiliation": "Division of Infectious Disease Pathology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan."}], "LastName": "Indrasetiawan", "ForeName": "Puguh", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan."}], "LastName": "Aoki-Utsubo", "ForeName": "Chie", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Chemistry, Indonesian Institute of Sciences (LIPI), Kawasan Puspiptek, Serpong 15314, Indonesia."}], "LastName": "Hanafi", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Chemistry, Indonesian Institute of Sciences (LIPI), Kawasan Puspiptek, Serpong 15314, Indonesia."}], "LastName": "Hartati", "ForeName": "Sri", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Disease, Airlangga University, Jalan Mulyorejo, Surabaya 60115, Indonesia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Airlangga University, Jalan Dharmawangsa Dalam, Surabaya 60286, Indonesia."}], "LastName": "Wahyuni", "ForeName": "Tutik Sri", "Initials": "TS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan."}], "LastName": "Kameoka", "ForeName": "Masanori", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Disease Pathology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan."}], "LastName": "Yano", "ForeName": "Yoshihiko", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan."}, {"Identifier": [], "Affiliation": "Faculty of Clinical Nutrition and Dietetics, Konan Women's University, 6-2-23 Morikita-machi, Higashinada-ku, Kobe 658-0001, Japan."}], "LastName": "Hotta", "ForeName": "Hak", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan."}, {"Identifier": [], "Affiliation": "Division of Infectious Disease Pathology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan."}], "LastName": "Hayashi", "ForeName": "Yoshitake", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Kobe J Med Sci", "NlmUniqueID": "0413531", "ISSNLinking": "0023-2513"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["analysis"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cananga"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hepatitis B"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hepatitis B virus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Indonesia"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18036.", "ArticleIdList": ["29877316"]}, {"Citation": "Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.", "ArticleIdList": ["26231459"]}, {"Citation": "Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Ranst MV, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol. 2014;20:7152\u201368.", "ArticleIdList": ["PMC4064061", "24966586"]}, {"Citation": "Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009;137:1593\u2013608.e2.", "ArticleIdList": ["19737565"]}, {"Citation": "Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1:e00049.", "ArticleIdList": ["PMC3485615", "23150796"]}, {"Citation": "Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother. 1997;41:1715\u201320.", "ArticleIdList": ["PMC163991", "9257747"]}, {"Citation": "Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA. 1987;84:1005\u20139.", "ArticleIdList": ["PMC304350", "3029758"]}, {"Citation": "Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun. 2014;443:808\u201313.", "ArticleIdList": ["24342612"]}, {"Citation": "Li FS, Weng JK. Demystifying traditional herbal medicine with modern approach. Nat Plants. 2017;3:17109.", "ArticleIdList": ["28758992"]}, {"Citation": "Siddiqui MH, Alamri SA, Al-Whaibi MH, Hussain Z, Ali HM, El-Zaidy ME. A mini-review of anti-hepatitis B virus activity of medicinal plants. Biotechnol Biotechnol Equip. 2017;31:9\u201315."}, {"Citation": "Geng CA, Chen JJ. The progress of anti-HBV constituents from medicinal plants in China. Nat Prod Bioprospect. 2018;8:227\u201344.", "ArticleIdList": ["PMC6102174", "29978386"]}, {"Citation": "Arbab AH, Parvez MK, Al-Dosari MS, Al-Rehaily AJ. In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Exp Ther Med. 2017;14:626\u201334.", "ArticleIdList": ["PMC5488430", "28672977"]}, {"Citation": "Huang KL, Lai YK, Lin CC, Chang JM. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2.2.15 cells. World J Gastroenterol. 2006;12:5721\u20135.", "ArticleIdList": ["PMC4088177", "17007029"]}, {"Citation": "Nugraha AS, Keller PA. Revealing indigenous Indonesian traditional medicine: anti-infective agents. Nat Prod Commun. 2011;6:1953\u201366.", "ArticleIdList": ["22312747"]}, {"Citation": "Iwamoto M, Cai D, Sugiyama M, Suzuki R, Aizaki H, Ryo A, Ohtani N, Tanaka Y, Mizokami M, Wakita T, Guo H, Watashi K. Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication. Sci Rep. 2017;7:10620.", "ArticleIdList": ["PMC5587681", "28878350"]}, {"Citation": "Apriyanto DR, Aoki C, Hartati S, Hanafi M, Kardono LBS, Arsianti A, Louisa M, Sudiro TM, Dewi BE, Sudarmono P, Soebandrio A, Hotta H. Anti-hepatitis C virus activity of a crude extract from longan (Dimocarpus longan Lour.) leaves. Jpn J Infect Dis. 2016;69:213\u201320.", "ArticleIdList": ["26255732"]}, {"Citation": "Lenhoff RJ, Summers J. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol. 1994;68:4565.18.", "ArticleIdList": ["PMC236383", "8207830"]}, {"Citation": "Watashi K, Liang G, Iwamoto M, Marusawa H, Uchida N, Daito T, Kitamura K, Muramatsu M, Ohashi H, Kiyohara T, Suzuki R, Li J, Tong S, Tanaka Y, Murata K, Aizaki H, Wakita T. Interleukin-1 and tumor necrosis factor-\u03b1 trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID) J Biol Chem. 2013;288:31715\u201327.", "ArticleIdList": ["PMC3814766", "24025329"]}, {"Citation": "Lamontagne J, Mills C, Mao R, Goddard C, Cai D, Guo H, Cuconati A, Block T, Lu X. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system. Antiviral Res. 2013;98:19\u201326.", "ArticleIdList": ["PMC3628437", "23415884"]}, {"Citation": "Ying C, Li Y, Leung CH, Robek MD, Cheng YC. Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue. Proc Natl Acad Sci USA. 2007;104:8526.", "ArticleIdList": ["PMC1895983", "17488817"]}, {"Citation": "Hayashi M, Deng L, Chen M, Gan X, Shinozaki K, Shoji I, Hotta H. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation. Microbiol Immunol. 2016;60:17\u201325.", "ArticleIdList": ["26616333"]}, {"Citation": "Kakizaki M, Yamamoto Y, Yabuta S, Kurosaki N, Kagawa T, Kotani A. The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes. PLoS One. 2018;13:e0205886.", "ArticleIdList": ["PMC6312312", "30596665"]}, {"Citation": "Watashi K, Sluder A, Daito T, Matsunaga S, Ryo A, Nagamori S, Iwamoto M, Nakajima S, Tsukuda S, Borroto-Esoda K, Sugiyama M, Tanaka Y, Kanai Y, Kusuhara H, Mizokami M, Wakita T. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) Hepatology. 2014;59:1726\u201337.", "ArticleIdList": ["PMC4265264", "24375637"]}, {"Citation": "Tan LTH, Lee LH, Yin WF, Chan CK, Kadir HA, Chan KG, Goh BH. Traditional uses, phytochemistry, and bioactivities of Cananga odorata (ylang-ylang) Evid Based Complement Alternat Med. 2015;2015 896314.", "ArticleIdList": ["PMC4534619", "26294929"]}, {"Citation": "Nguyen-Pouplin J, Tran H, Tran H, Phan TA, Dolecek C, Farrar J, Tran TH, Caron P, Bodo B, Grellier P. Antimalarial and cytotoxic activities of ethnopharmacologically selected medicinal plants from South Vietnam. J Ethnopharmacol. 2007;109:417\u201327.", "ArticleIdList": ["17010546"]}, {"Citation": "Indrakumar I, Selvi V, Gomathi R, Karpagam S. Evaluation of antimicrobial activity of Cananga odorata (Lam.) Hook. F & Thomson leaf extract: an in vitro study. Mintage J Pharm Med Sci. 2012;1:21\u20132."}, {"Citation": "Matsunami K, Nagashima J, Sugimoto S, Otsuka H, Takeda Y, Lhieochaiphant D, Lhieochaiphant S. Megastigmane glucosides and an unusual monoterpene from the leaves of Cananga odorata var. odorata, and absolute structures of megastigmane glucosides isolated from C. odorata var. odorata and Breynia officinalis. J Nat Med. 2010;64:460\u20137.", "ArticleIdList": ["20571926"]}, {"Citation": "Nagashima J, Matsunami K, Otsuka H, Lhieochaiphant D, Lhieochaiphant S. The unusual canangafruticosides A\u2013E: five monoterpene glucosides, two monoterpenes and a monoterpene glucoside diester of the aryldihydronaphthalene lignan dicarboxylic acid from leaves of Cananga odorata var. fruticosa. Phytochemistry. 2010;71:1564\u201372.", "ArticleIdList": ["20619865"]}, {"Citation": "Katsui H, Sugimoto S, Matsunami K, Otsuka H, Lhieochaiphant S. Lignan diesters of canangafruticoside A from the leaves of Cananga odorata var. odorata. Chem Pharm Bull. 2017;65:97\u2013101.", "ArticleIdList": ["28049920"]}, {"Citation": "Rahmani AH. Cassia fistula Linn: potential candidate in the health management. Pharmacognosy Res. 2015;7:217\u201324.", "ArticleIdList": ["PMC4471647", "26130932"]}, {"Citation": "Kainsa S, Kumar P, Rani P. Pharmacological potentials of Cassia auriculata and Cassia fistula plants: a review. Pak J Biol Sci. 2012;15:408\u201317.", "ArticleIdList": ["24163950"]}, {"Citation": "Rehman G, Hamayun M, Iqbal A, Arshad S, Zaman K, Ahmad A, Shehzad A, Hussain A, Lee IJ. In vitro antidiabetic effects and antioxidant potential of Cassia nemophila Pods. Biomed Res Int. 2018;2018:6.", "ArticleIdList": ["PMC5827890", "29607313"]}, {"Citation": "Sobeh M, Mahmoud MF, Abdelfattah MAO, Cheng H, El-Shazly AM, Wink M. A proanthocyanidin-rich extract from Cassia abbreviata exhibits antioxidant and hepatoprotective activities in vivo. J Ethnopharmacol. 2018;213:38\u201347.", "ArticleIdList": ["29126990"]}, {"Citation": "Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH. Inhibitory effects of amentoflavone and orobol on daclatasvir-induced resistance-associated variants of hepatitis C virus. Am J Chin Med. 2018;46:835\u201352.", "ArticleIdList": ["29737209"]}, {"Citation": "Lin YM, Flavin MT, Schure R, Chen FC, Sidwell R, Barnard DL, Huffman JH, Kern ER. Antiviral activities of biflavonoids. Planta Med. 1999;65:120\u20135.", "ArticleIdList": ["10193201"]}, {"Citation": "Lin YM, Anderson H, Flavin MT, Pai YH, Mata-Greenwood E, Pengsuparp T, Pezzuto JM, Schinazi RF, Hughes SH, Chen FC. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J Nat Prod. 1997;60:884\u20138.", "ArticleIdList": ["9322359"]}, {"Citation": "Wu YH. Naturally derived anti-hepatitis B virus agents and their mechanism of action. World J Gastroenterol. 2016;22:188\u2013204.", "ArticleIdList": ["PMC4698485", "26755870"]}, {"Citation": "Joffry SM, Yob NJ, Rofiee MS, Affandi MMRMM, Suhaili Z, Othman F, Akim AM, Desa MNM, Zakaria ZA. Melastoma malabathricum (L.) Smith ethnomedicinal uses, chemical constituents, and pharmacological properties: a review. Evid Based Complement Alternat Med. 2012;2012 258434.", "ArticleIdList": ["PMC3254175", "22242040"]}, {"Citation": "Mamat SS, Kamarolzaman MFF, Yahya F, Mahmood ND, Shahril MS, Jakius KF, Mohtarrudin N, Ching SM, Susanti D, Taher M, Zakaria ZA. Methanol extract of Melastoma malabathricum leaves exerted antioxidant and liver protective activity in rats. BMC Complement Altern Med. 2013;13:326.", "ArticleIdList": ["PMC3879098", "24267313"]}, {"Citation": "Loh\u00e9zic-Le D\u00e9v\u00e9hat F, Bakhtiar A, B\u00e9zivin C, Amoros M, Boustie J. Antiviral and cytotoxic activities of some Indonesian plants. Fitoterapia. 2002;73:400\u20135.", "ArticleIdList": ["12165336"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["31956259", "PMC7012192"]}}], "PubmedBookArticle": []}